LR
Larry R. Brown, Sc.D.
Research & Development Executive Vice President/Chief Scientific Officer
Noveome BiotherapeuticsTherapeutic Areas
Noveome Biotherapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ST266 | Necrotizing Enterocolitis (NEC) in Premature Infants | Phase 1-2 |